Fixstars Corporation (TYO:3687)

Intra-Cellular Therapies Balance Sheet

Financials in millions JPY. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	4,618	4,856	4,629	5,056	4,681	5,593
Cash & Short-Term Investments	4,618	4,856	4,629	5,056	4,681	5,593
Cash Growth	3.82%	4.90%	-8.45%	8.01%	-16.31%	228.81%
Receivables	3,205	2,539	2,374	2,016	1,704	1,927
Inventory	15	30	5	7	9	4
Other Current Assets	171	347	304	126	42	210
Total Current Assets	8,009	7,772	7,312	7,205	6,436	7,734
Property, Plant & Equipment	300	323	253	351	452	76
Long-Term Investments	400	422	478	412	405	234
Other Intangible Assets	2	3	2	2	2	5
Long-Term Deferred Tax Assets	223	208	136	189	99	92
Other Long-Term Assets	2	1	1	2	2	2
Total Assets	8,936	8,729	8,182	8,161	7,396	8,143
Accounts Payable	172	114	134	175	156	160
Accrued Expenses	182	163	129	251	54	95
Current Portion of Long-Term Debt	75	493	804	795	795	795
Current Portion of Leases	22	21	-	19	38	15
Current Income Taxes Payable	316	528	301	499	206	253
Other Current Liabilities	512	435	496	543	395	372
Total Current Liabilities	1,279	1,754	1,864	2,282	1,644	1,690
Long-Term Debt	-	-	493	1,289	2,085	2,881
Long-Term Leases	21	32	-	-	17	23
Other Long-Term Liabilities	2	1	2	7	7	7
Total Liabilities	1,302	1,787	2,359	3,578	3,753	4,601
Common Stock	554	554	554	554	554	553
Additional Paid-In Capital	608	573	558	543	477	477
Retained Earnings	7,319	6,739	5,663	4,536	3,608	3,261
Treasury Stock	-1,263	-1,297	-1,332	-1,364	-1,100	-831
Comprehensive Income & Other	177	157	197	145	-5	-30
Total Common Equity	7,395	6,726	5,640	4,414	3,534	3,430
Minority Interest	239	216	183	169	109	112
Shareholders' Equity	7,634	6,942	5,823	4,583	3,643	3,542
Total Liabilities & Equity	8,936	8,729	8,182	8,161	7,396	8,143
Total Debt	118	546	1,297	2,103	2,935	3,714
Net Cash (Debt)	4,500	4,310	3,332	2,953	1,746	1,879
Net Cash Growth	26.76%	29.35%	12.83%	69.13%	-7.08%	10.46%
Net Cash Per Share	139.65	133.83	103.58	91.45	53.46	56.88
Filing Date Shares Outstanding	32.25	32.22	32.18	32.14	32.51	32.79
Total Common Shares Outstanding	32.25	32.22	32.18	32.14	32.51	32.79
Working Capital	6,730	6,018	5,448	4,923	4,792	6,044
Book Value Per Share	229.28	208.78	175.28	137.32	108.69	104.61
Tangible Book Value	7,393	6,723	5,638	4,412	3,532	3,425
Tangible Book Value Per Share	229.22	208.69	175.22	137.26	108.63	104.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.